Wade C. Barton

Obstetrics and Gynecology
101 Dudley St
Providence, RI 02905

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications

Specialty Palliative Care Consultation in Patients with Cervical Cancer: Who and Why?

Specialty Palliative Care Consultation in Patients with Cervical Cancer: Who and Why?

Journal: Journal of palliative medicine
Published: April 23, 2025

Targeting Mediator Kinase Cyclin-Dependent Kinases 8/19 Potentiates Chemotherapeutic Responses, Reverses Tumor Growth, and Prolongs Survival from Ovarian Clear Cell Carcinoma.

Targeting Mediator Kinase Cyclin-Dependent Kinases 8/19 Potentiates Chemotherapeutic Responses, Reverses Tumor Growth, and Prolongs Survival from Ovarian Clear Cell Carcinoma.

Journal: Cancers
Published: January 22, 2025

Targeted therapy in high grade serous ovarian Cancer: A literature review.

Targeted therapy in high grade serous ovarian Cancer: A literature review.

Journal: Gynecologic oncology reports
Published: May 17, 2024

Glycosaminoglycan modifications of betaglycan regulate ectodomain shedding to fine-tune TGF-β signaling responses in ovarian cancer.

Glycosaminoglycan modifications of betaglycan regulate ectodomain shedding to fine-tune TGF-β signaling responses in ovarian cancer.

Journal: Cell communication and signaling : CCS
Published: September 14, 2023

Heparan sulfate modifications of betaglycan promote TIMP3-dependent ectodomain shedding to fine-tune TGF-β signaling.

Heparan sulfate modifications of betaglycan promote TIMP3-dependent ectodomain shedding to fine-tune TGF-β signaling.

Journal: bioRxiv : the preprint server for biology
Published: September 11, 2023
Showing 1-5 of 5

Last Updated: 09/26/2026